Physician
Advocare, LLC
Advocare, LLC was paid $32.12M by Medicaid between Jan 2018 and Dec 2024, across 172 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 37% of everything it billed.
33Billing provider infoADVOCARE, LLC
MARLTON, NJ 08053
MARLTON, NJ 08053
33aNPI1770538696assigned 05/23/2006
33bProvider typeFamily Medicine Physician
28Total paid$32.12M
24GClaims695,396
24DCodes billed172
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Family Medicine Physician providers in New Jersey
Rank by total paid#1 of 414
Median peer was paid$28K
This provider vs. median1,139×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official CANDIA, DAWN controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 556 | $38K | |
| 2019 | 29,396 | $1.52M | |
| 2020 | 71,617 | $3.44M | |
| 2021 | 135,583 | $7.21M | |
| 2022 | 181,865 | $8.05M | |
| 2023 | 91,196 | $2.35M | |
| 2024incomplete | 185,183 | $9.51M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 37% | 181,395 | 161,796 | $11.80M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 30% | 110,571 | 100,014 | $9.63M |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 5.0% | 43,919 | 42,873 | $1.60M |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 3.7% | 11,733 | 11,614 | $1.18M |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 3.4% | 10,523 | 10,469 | $1.08M |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 2.6% | 9,022 | 8,735 | $824K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 2.4% | 37,878 | 37,452 | $777K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 2.3% | 6,729 | 6,678 | $754K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 1.5% | 14,114 | 13,136 | $474K |
| 90461 | <1% | 7,758 | 7,475 | $252K | |
| 87428 | <1% | 3,516 | 3,404 | $246K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 18,248 | 9,626 | $231K |
160 more codes
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 1,724 | $215K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 1,551 | $208K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 15,128 | $185K |
| 90677 | <1% | 923 | $184K | |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 12,145 | $176K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 5,263 | $157K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 1,572 | $137K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 15,307 | $128K |
| 99308 | Subsequent nursing facility care, per day, straightforward | <1% | 7,275 | $123K |
| 93924 | <1% | 881 | $121K | |
| 90697 | <1% | 970 | $118K | |
| 92551 | <1% | 11,966 | $110K | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 755 | $101K |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | <1% | 859 | $99K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 1,927 | $97K |
| 92015 | Determination of refractive state | <1% | 4,934 | $88K |
| 95004 | Percutaneous tests with allergenic extracts, immediate type reaction | <1% | 490 | $65K |
| 31231 | <1% | 368 | $63K | |
| 96127 | <1% | 15,667 | $59K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 432 | $50K |
| 92552 | <1% | 1,534 | $41K | |
| 92060 | <1% | 944 | $35K | |
| 95117 | <1% | 3,550 | $29K | |
| 90686 | <1% | 27,701 | $29K | |
| 99385 | <1% | 262 | $28K | |
| 95165 | Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials | <1% | 100 | $26K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 2,865 | $26K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 1,947 | $26K |
| J0717 | Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | <1% | 36 | $25K |
| 90619 | <1% | 154 | $24K | |
| 99306 | Prolong nursin fac eval 15m | <1% | 306 | $22K |
| 99177 | <1% | 4,149 | $21K | |
| 90651 | <1% | 1,380 | $20K | |
| 92588 | <1% | 601 | $20K | |
| 20610 | <1% | 404 | $19K | |
| 92587 | <1% | 1,163 | $19K | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 2,065 | $19K |
| 99232 | Hospital visit by a doctor, follow-up day | <1% | 847 | $18K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 1,009 | $17K |
| 92511 | <1% | 162 | $16K | |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 220 | $14K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 348 | $14K |
| 99384 | <1% | 87 | $14K | |
| 90670 | <1% | 4,990 | $13K | |
| 92557 | <1% | 408 | $12K | |
| 97014 | <1% | 480 | $12K | |
| 69210 | <1% | 340 | $12K | |
| 0071A | <1% | 309 | $11K | |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | <1% | 78 | $11K |
| 31575 | <1% | 92 | $9K | |
| 90734 | <1% | 445 | $9K | |
| 99459 | <1% | 416 | $8K | |
| 90710 | <1% | 1,285 | $8K | |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 64 | $8K |
| 95800 | <1% | 151 | $7K | |
| 80305 | <1% | 797 | $7K | |
| 90474 | <1% | 646 | $7K | |
| 99334 | <1% | 402 | $6K | |
| 0072A | <1% | 199 | $6K | |
| 99383 | <1% | 49 | $6K | |
| 90682 | <1% | 191 | $6K | |
| 90656 | <1% | 4,199 | $5K | |
| 90671 | <1% | 51 | $5K | |
| 99173 | <1% | 34,695 | $4K | |
| 95024 | <1% | 30 | $4K | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 804 | $4K |
| 90620 | <1% | 278 | $4K | |
| 99233 | Hospital visit by a doctor, follow-up day (complex) | <1% | 91 | $3K |
| 92550 | <1% | 232 | $3K | |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 1,395 | $3K |
| 90698 | <1% | 1,862 | $3K | |
| 90633 | <1% | 1,924 | $2K | |
| 86328 | <1% | 53 | $2K | |
| 99223 | Prolong inpt eval add15 m | <1% | 51 | $2K |
| 99487 | Ccm add 20min | <1% | 28 | $2K |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 38 | $2K |
| 96401 | <1% | 18 | $2K | |
| 99460 | <1% | 25 | $2K | |
| 88738 | <1% | 517 | $2K | |
| 99381 | <1% | 14 | $2K | |
| 91320 | <1% | 15 | $2K | |
| S9083 | Global fee urgent care centers | <1% | 19 | $2K |
| 96160 | <1% | 950 | $2K | |
| 94010 | <1% | 56 | $2K | |
| 94664 | <1% | 97 | $1K | |
| 90674 | <1% | 80 | $1K | |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | <1% | 111 | $1K |
| 91065 | <1% | 22 | $1K | |
| 99348 | <1% | 276 | $1K | |
| 90621 | <1% | 29 | $1K | |
| 99243 | <1% | 12 | $1K | |
| 90480 | <1% | 37 | $1K | |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 214 | $1K |
| 97802 | <1% | 449 | $1K | |
| 0001A | <1% | 30 | $1K | |
| 73560 | <1% | 37 | $1K | |
| 90715 | <1% | 662 | $1K | |
| 99347 | <1% | 122 | $1K | |
| 99239 | Hospital discharge day management, more than 30 minutes | <1% | 53 | $1K |
| 36415 | Collection of venous blood by venipuncture | <1% | 582 | $1K |
| 92567 | <1% | 73 | $991.18 | |
| 99309 | Subsequent nursing facility care, per day, low to moderate complexity | <1% | 30 | $944.98 |
| 96161 | <1% | 567 | $898.34 | |
| 90681 | <1% | 772 | $877.84 | |
| 99305 | <1% | 17 | $868.18 | |
| 99174 | <1% | 186 | $792.54 | |
| 81025 | <1% | 102 | $709.19 | |
| 90696 | <1% | 389 | $680.40 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 59 | $675.31 |
| 93000 | <1% | 119 | $626.57 | |
| 90473 | <1% | 40 | $617.70 | |
| 90673 | <1% | 112 | $588.58 | |
| 90680 | <1% | 720 | $583.64 | |
| 0081A | <1% | 14 | $560.00 | |
| 90723 | <1% | 350 | $509.11 | |
| 95806 | <1% | 14 | $479.84 | |
| 90688 | <1% | 302 | $474.59 | |
| 97162 | <1% | 12 | $420.00 | |
| 99072 | <1% | 3,749 | $400.00 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 40 | $364.72 |
| G0444 | Annual depression screening, 5 to 15 minutes | <1% | 32 | $361.72 |
| 83655 | <1% | 148 | $360.00 | |
| 36416 | <1% | 372 | $240.00 | |
| 99324 | <1% | 13 | $207.00 | |
| 81002 | <1% | 1,055 | $204.96 | |
| 90792 | Psychiatric diagnostic evaluation with medical services | <1% | 13 | $190.34 |
| 99188 | <1% | 13 | $186.66 | |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 278 | $138.92 |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 111 | $137.40 |
| 90744 | <1% | 325 | $112.00 | |
| 81000 | <1% | 73 | $101.50 | |
| S8110 | Peak expiratory flow rate (physician services) | <1% | 17 | $68.90 |
| 90647 | <1% | 38 | $25.25 | |
| 99000 | <1% | 1,987 | $22.28 | |
| 90648 | <1% | 95 | $20.52 | |
| 90833 | Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) | <1% | 116 | $20.06 |
| 97010 | <1% | 1,564 | $14.00 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 14 | $14.00 |
| 94760 | <1% | 1,573 | $4.59 | |
| 3008F | 0% | 3,495 | $0.00 | |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | 0% | 934 | $0.00 |
| 87807 | 0% | 1,697 | $0.00 | |
| 91307 | 0% | 713 | $0.00 | |
| 99024 | 0% | 355 | $0.00 | |
| 87081 | 0% | 1,898 | $0.00 | |
| S0302 | Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) | 0% | 34 | $0.00 |
| 3074F | 0% | 26 | $0.00 | |
| 99070 | 0% | 24 | $0.00 | |
| G0008 | Administration of influenza virus vaccine | 0% | 26 | $0.00 |
| 90716 | 0% | 21 | $0.00 | |
| 99051 | 0% | 604 | $0.00 | |
| 91300 | 0% | 154 | $0.00 | |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | 0% | 741 | $0.00 |
| 4551F | 0% | 77 | $0.00 | |
| 91308 | 0% | 60 | $0.00 | |
| 90672 | 0% | 37 | $0.00 | |
| G8417 | Bmi is documented above normal parameters and a follow-up plan is documented | 0% | 26 | $0.00 |
| 90707 | 0% | 44 | $0.00 | |
| 90661 | 0% | 37 | $0.00 | |
| 3078F | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialCANDIA, DAWN (DIRECTOR OF CREDENTIALING)
| Provider | Location | Paid |
|---|---|---|
| Advocare, LLC | Cedar Knolls, NJ | $769K |
| Advocare, LLC | Cherry Hill, NJ | $719K |
| Einstein Practice Plan, INC. | Philadelphia, PA | $594K |
| Advocare, LLC | West Deptford, NJ | $580K |
| Advocare, LLC | Blackwood, NJ | $462K |
| Advocare, LLC | Union City, NJ | $360K |
| Advocare LLC | Bergenfield, NJ | $329K |
| Advocare, LLC | Delran, NJ | $272K |
| Advocare, LLC | Voorhees, NJ | $253K |
| Advocare, LLC | Wenonah, NJ | $192K |
| Advocare, LLC | East Brunswick, NJ | $150K |
| Advocare , LLC | Philadelphia, PA | $125K |
| Advocare, LLC | Mt Arlington, NJ | $109K |
| Advocare , LLC | Clifton, NJ | $81K |
| Einstein Practice Plan, INC. | Philadelphia, PA | $77K |
| Advocare , LLC | Marlton, NJ | $71K |
| Advocare , LLC | Berlin, NJ | $55K |
| Advocare LLC | Englewood, NJ | $48K |
| Advocare, LLC | Haddonfield, NJ | $39K |
| Advocare, LLC | Sewell, NJ | $31K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.